Teva Pharmaceutical Industries Limited (TEVA)

NYSE: TEVA · Real-Time Price · USD

36.77

+0.25 (0.68%)

At close: Aug 14, 2026, 4:00 PM EDT

36.75

-0.02 (-0.05%)

After-hours: Aug 14, 2026, 7:50 PM EDT

Teva Pharmaceutical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	706	1,410	-1,639	-559	-2,446	417
Depreciation & Amortization	988	1,002	1,059	1,153	1,308	1,330
Loss (Gain) From Sale of Assets	-20	-	-22	-41	10	-
Asset Writedown & Restructuring Costs	1,697	1,028	2,555	1,078	2,447	594
Loss (Gain) From Sale of Investments	-	-	-	-	-	104
Stock-Based Compensation	168	157	123	121	124	119
Other Operating Activities	-530	-582	-394	-312	-1,208	-65
Change in Accounts Receivable	-7	-173	245	12	334	-574
Change in Inventory	181	152	166	-147	-163	380
Change in Accounts Payable	-123	-15	258	1,588	2,012	764
Change in Other Net Operating Assets	-1,162	-1,330	-1,104	-1,525	-828	-2,271
Operating Cash Flow	1,898	1,649	1,247	1,368	1,590	798
Operating Cash Flow Growth	36.55%	32.24%	-8.85%	-13.96%	99.25%	-34.38%
Capital Expenditures	-551	-501	-498	-526	-548	-562
Cash Acquisitions	-696	-	-15	-	-7	-
Divestitures	54	34	43	68	68	311
Investment in Securities	11	-15	-31	-46	3	125
Other Investing Activities	-2	5	2	-5	-	1
Investing Cash Flow	37	737	792	968	656	1,523
Short-Term Debt Issued	-	-	-	700	-	700
Long-Term Debt Issued	-	2,298	-	2,451	-	4,974
Total Debt Issued	-7	2,298	-	3,151	-	5,674
Short-Term Debt Repaid	-	-	-	-700	-	-700
Long-Term Debt Repaid	-	-4,112	-1,641	-4,152	-1,369	-7,140
Total Debt Repaid	-467	-4,112	-1,641	-4,852	-1,369	-7,840
Net Debt Issued (Repaid)	-474	-1,814	-1,641	-1,701	-1,369	-2,166
Other Financing Activities	73	-337	-150	-212	-118	-6
Financing Cash Flow	-401	-2,151	-1,791	-1,913	-1,487	-2,172
Foreign Exchange Rate Adjustments	-41	21	-174	-30	-123	-128
Net Cash Flow	1,494	256	74	393	636	21
Free Cash Flow	1,347	1,148	749	842	1,042	236
Free Cash Flow Growth	51.35%	53.27%	-11.04%	-19.19%	341.52%	-63.01%
Free Cash Flow Margin	7.78%	6.65%	4.53%	5.31%	6.98%	1.49%
Free Cash Flow Per Share	1.16	0.99	0.66	0.75	0.94	0.21
Levered Free Cash Flow	2,220	2,032	2,623	3,298	2,900	2,307
Unlevered Free Cash Flow	2,758	2,604	3,249	3,941	3,481	2,863
Cash Interest Paid	950	950	1,004	1,078	948	913
Cash Income Tax Paid	558	558	471	298	543	495
Change in Working Capital	-1,111	-1,366	-435	-72	1,355	-1,701

SEC Filings: 10-K · 10-Q